Last reviewed · How we verify

NCT07023185

Cold and Compression After Total Knee Arthroplasty for Pain Attenuation: A Randomized, Controlled Trial

Recruiting now NA Last updated 1 April 2026
What this trial tests

NA trial testing Cold and Compression in Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery in 90 participants. Currently enrolling.

Timeline
15 December 2025
Primary endpoint
1 June 2027
1 June 2028

Quick facts

Lead sponsorOchsner Health System
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment90
Start date15 December 2025
Primary completion1 June 2027
Estimated completion1 June 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ochsner Health System — full company profile →

Who can join

50 and older, any sex, with Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose of this study is to compare pain score (Patient-Reported Outcomes Measurement Information System: PROMIS NRS Pain Subscale) between the control and cold/compression groups pre-surgically, daily after surgery for 14 days, then weekly after surgery for 3 months, and at 6 months post-surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cold and Compression

Trials testing the same drug.

Other Ochsner Health System trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07023185.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing